(June 10, 2014 – Sarasota, FL)  This week Dattoli Cancer Center & Brachytherapy Research Institute became the first independent physician practice in the U.S. to offer men with advanced metastatic prostate cancer an injectable isotope of radium, marketed by Bayer as Xofigo® (zoh-fee-go).  This new pharmaceutical was recently FDA approved for use in men with […]

New Ultrasound Technology Debuts at Dattoli Cancer Center

(June 18, 2010 – Sarasota, FL) Dattoli Cancer Center has invested in the newest color-flow Doppler ultrasound technology for its prostate cancer treatment center and brachytherapy (seed implant) suite. The Hitachi “HI VISION 900” is the latest generation premium class, high-resolution ultrasound system representing a genuine advance in image quality and clinical utility. The equipment […]

Dattoli Cancer Center CT Lab ICACTL-Accredited

(June 7, 2010 – Sarasota, FL) The computed tomography laboratory at Dattoli Cancer Center & Brachytherapy Research Institute has been notified that it has been granted accreditation by the Intersocietal Commission for the Accreditation of Computed Tomography Laboratories (ICACTL). The laboratory, supervised by Donald Bryant, R.T.(R)(T)(C) ARRT, under the direction of Michael Dattoli, MD, is […]

Dattoli Participates in Mount Sinai

DATTOLI PARTICIPATES IN MOUNT SINAI RUDIN-KASE DEAN’S LECTURE SERIES (April 5, 2010 – Sarasota, FL) Dr. Michael Dattoli, founder and physician-in-chief of the Dattoli Cancer Center & Brachytherapy Research Institute in Sarasota, has just returned from speaking to a group of physicians at Mount Sinai School of Medicine in New York City. Dattoli participated in […]

Next Generation Prostate Ultrasound Studies

Tuesday, June 1, 2004 Next Generation Prostate Ultrasound Studies Debut at Dattoli Cancer Center Accurately diagnosing prostate cancer is essential to successful treatment. The widely used PSA blood test is only an indication of the relative health of the prostate gland, and as recent studies indicate, a low PSA can give a false sense of […]